• Sheraton New York Times Square Hotel (map)
  • 811 7th Avenue
  • New York, NY, 10019
  • United States

Session Chairs: Wolf Herve Fridman, Cordeliers Research Center, Paris, France, and Shannon J. Turley, Genentech, Inc., South San Francisco, CA

8:40 a.m.  Wolf Herve Fridman, Cordeliers Research Center, Paris, France
Tumor microenvironments: Prognostic and theranostic impacts

9:20 a.m.  Shannon J. Turley, Genentech, Inc., South San Francisco, CA
Emerging insights into stromal cell function in immune homeostasis and inflammation

9:50 a.m.  Shimon Sakaguchi, Osaka University, Osaka, Japan
Targeting regulatory T cells for cancer immunotherapy

10:20 a.m.  Refreshment Break

10:50 a.m.  Vincenzo Bronte, University of Verona, Verona, Italy
Immune suppressive and immune stimulating monocytes in cancer

11:20 a.m.  Alexander Huang, University of Pennsylvania, Philadelphia, PA
Peripheral blood immune profiling of anti-PD-1 therapy in human melanoma reveals a link between T cell re-invigoration and tumor burden that predicts response*

11:35 a.m.  Taha Merghoub, Memorial Sloan Kettering Cancer Center, New York, NY
Overcoming intratumor T-cell exclusion by modulation of lactate metabolism to improve immune checkpoint therapies in aggressive breast cancer*

11:50 a.m.  David G. DeNardo, Washington University School of Medicine, St. Louis, MO
Targeting focal adhesion kinase to awaken responses to immunotherapy in pancreatic cancer

* Proffered presentation